SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$1.20
-0.02 (-1.64%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,920.0% upside
Low Target
$26.81
Average Target
$36.24
High Target
$52.45
Current Price
$1.20
Current
$1.20
$1.20
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Scenario Analysis
Bear Case
$26.81
2,134.2%
Low target
Base Case
$36.24
+2,920.0%
Avg target
Bull Case
$52.45
+4,270.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$22.36
-94.6% from high
52-Week Low
$1.07
+12.1% from low
Target vs 52W High
$36.24
+62.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +18.4% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.8% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +160.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -1.8% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.1% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -28.5% |